A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS

N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Allen, Rodger Anthony, Kracker, Sven, McHale, Duncan Philip, Armstrong, Martin John, Cavazzana, Marina, Payne, Andrew Charles
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Allen, Rodger Anthony Kracker, Sven McHale, Duncan Philip Armstrong, Martin John Cavazzana, Marina Payne, Andrew Charles
description	N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019209567A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019209567A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019209567A13</originalsourceid><addsrcrecordid>eNrjZPB1VAguSE3OTMtMVggpykzLKc0vyk8tyajMUQgszczLz8nMS1VwzEvMyU8vTVVwyy9SCC1OVfDMUwjJSAVqSE0syU3NK1HIT1NwDHAJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlkYGlqZm5o6GxsSpAgAKVDWq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS</title><source>esp@cenet</source><creator>Allen, Rodger Anthony ; Kracker, Sven ; McHale, Duncan Philip ; Armstrong, Martin John ; Cavazzana, Marina ; Payne, Andrew Charles</creator><creatorcontrib>Allen, Rodger Anthony ; Kracker, Sven ; McHale, Duncan Philip ; Armstrong, Martin John ; Cavazzana, Marina ; Payne, Andrew Charles</creatorcontrib><description>N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190711&DB=EPODOC&CC=US&NR=2019209567A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190711&DB=EPODOC&CC=US&NR=2019209567A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Allen, Rodger Anthony</creatorcontrib><creatorcontrib>Kracker, Sven</creatorcontrib><creatorcontrib>McHale, Duncan Philip</creatorcontrib><creatorcontrib>Armstrong, Martin John</creatorcontrib><creatorcontrib>Cavazzana, Marina</creatorcontrib><creatorcontrib>Payne, Andrew Charles</creatorcontrib><title>A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS</title><description>N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB1VAguSE3OTMtMVggpykzLKc0vyk8tyajMUQgszczLz8nMS1VwzEvMyU8vTVVwyy9SCC1OVfDMUwjJSAVqSE0syU3NK1HIT1NwDHAJ5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGlkYGlqZm5o6GxsSpAgAKVDWq</recordid><startdate>20190711</startdate><enddate>20190711</enddate><creator>Allen, Rodger Anthony</creator><creator>Kracker, Sven</creator><creator>McHale, Duncan Philip</creator><creator>Armstrong, Martin John</creator><creator>Cavazzana, Marina</creator><creator>Payne, Andrew Charles</creator><scope>EVB</scope></search><sort><creationdate>20190711</creationdate><title>A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS</title><author>Allen, Rodger Anthony ; Kracker, Sven ; McHale, Duncan Philip ; Armstrong, Martin John ; Cavazzana, Marina ; Payne, Andrew Charles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019209567A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Allen, Rodger Anthony</creatorcontrib><creatorcontrib>Kracker, Sven</creatorcontrib><creatorcontrib>McHale, Duncan Philip</creatorcontrib><creatorcontrib>Armstrong, Martin John</creatorcontrib><creatorcontrib>Cavazzana, Marina</creatorcontrib><creatorcontrib>Payne, Andrew Charles</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Allen, Rodger Anthony</au><au>Kracker, Sven</au><au>McHale, Duncan Philip</au><au>Armstrong, Martin John</au><au>Cavazzana, Marina</au><au>Payne, Andrew Charles</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS</title><date>2019-07-11</date><risdate>2019</risdate><abstract>N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2019209567A1
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Allen,%20Rodger%20Anthony&rft.date=2019-07-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019209567A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true